Cargando…
The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
Autores principales: | May, Jori E., Siniard, Rance C., Marques, Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404754/ https://www.ncbi.nlm.nih.gov/pubmed/32838112 http://dx.doi.org/10.1002/rth2.12416 |
Ejemplares similares
-
Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: Riker, Richard R., et al.
Publicado: (2020) -
Heparin-induced thrombocytopenia: An illustrated review
por: May, Jori, et al.
Publicado: (2023) -
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021) -
Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020) -
Heparin induced thrombocytopenia-type 2
por: Majeed, Tanveer A.
Publicado: (2010)